{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:43:30Z","timestamp":1774435410189,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T00:00:00Z","timestamp":1154217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1038\/ng1855","type":"journal-article","created":{"date-parts":[[2006,7,30]],"date-time":"2006-07-30T13:51:45Z","timestamp":1154267505000},"page":"1060-1065","source":"Crossref","is-referenced-by-count":844,"title":["Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster"],"prefix":"10.1038","volume":"38","author":[{"given":"Michael","family":"Dews","sequence":"first","affiliation":[]},{"given":"Asal","family":"Homayouni","sequence":"additional","affiliation":[]},{"given":"Duonan","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Danielle","family":"Murphy","sequence":"additional","affiliation":[]},{"given":"Cinzia","family":"Sevignani","sequence":"additional","affiliation":[]},{"given":"Erik","family":"Wentzel","sequence":"additional","affiliation":[]},{"given":"Emma E","family":"Furth","sequence":"additional","affiliation":[]},{"given":"William M","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Greg H","family":"Enders","sequence":"additional","affiliation":[]},{"given":"Joshua T","family":"Mendell","sequence":"additional","affiliation":[]},{"given":"Andrei","family":"Thomas-Tikhonenko","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,7,30]]},"reference":[{"key":"BFng1855_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1097-2765(00)80350-0","volume":"3","author":"S Pelengaris","year":"1999","unstructured":"Pelengaris, S., Littlewood, T., Khan, M., Elia, G. & Evan, G.I. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3, 565\u2013577 (1999).","journal-title":"Mol. Cell"},{"key":"BFng1855_CR2","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1038\/sj.onc.1203589","volume":"19","author":"KA Brandvold","year":"2000","unstructured":"Brandvold, K.A., Neiman, P. & Ruddell, A. Angiogenesis is an early event in the generation of myc-induced lymphomas. Oncogene 19, 2780\u20132785 (2000).","journal-title":"Oncogene"},{"key":"BFng1855_CR3","first-page":"201","volume":"11","author":"C Ngo","year":"2000","unstructured":"Ngo, C. et al. An in vivo function for the transforming myc protein: elicitation of the angiogenic phenotype. Cell Growth Differ. 11, 201\u2013210 (2000).","journal-title":"Cell Growth Differ."},{"key":"BFng1855_CR4","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1101\/gad.1024602","volume":"16","author":"TA Baudino","year":"2002","unstructured":"Baudino, T.A. et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16, 2530\u20132543 (2002).","journal-title":"Genes Dev."},{"key":"BFng1855_CR5","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/S0002-9440(10)63581-X","volume":"163","author":"A Ruddell","year":"2003","unstructured":"Ruddell, A., Mezquita, P., Brandvold, K.A., Farr, A. & Iritani, B.M. B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis. Am. J. Pathol. 163, 2233\u20132245 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFng1855_CR6","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1158\/0008-5472.CAN-03-3176","volume":"64","author":"UE Knies-Bamforth","year":"2004","unstructured":"Knies-Bamforth, U.E., Fox, S.B., Poulsom, R., Evan, G.I. & Harris, A.L. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism. Cancer Res. 64, 6563\u20136570 (2004).","journal-title":"Cancer Res."},{"key":"BFng1855_CR7","doi-asserted-by":"publisher","first-page":"30741","DOI":"10.1074\/jbc.271.48.30741","volume":"271","author":"AT Tikhonenko","year":"1996","unstructured":"Tikhonenko, A.T., Black, D.J. & Linial, M.L. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem. 271, 30741\u201330747 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFng1855_CR8","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1093\/nar\/28.11.2268","volume":"28","author":"A Janz","year":"2000","unstructured":"Janz, A., Sevignani, C., Kenyon, K., Ngo, C. & Thomas-Tikhonenko, A. Activation of the Myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA. Nucleic Acids Res. 28, 2268\u20132275 (2000).","journal-title":"Nucleic Acids Res."},{"key":"BFng1855_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1535-6108(03)00030-8","volume":"3","author":"RS Watnick","year":"2003","unstructured":"Watnick, R.S., Cheng, Y.N., Rangarajan, A., Ince, T.A. & Weinberg, R.A. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3, 219\u2013231 (2003).","journal-title":"Cancer Cell"},{"key":"BFng1855_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1172\/JCI919","volume":"101","author":"C Sevignani","year":"1998","unstructured":"Sevignani, C. et al. Tumorigenic conversion of p53-deficient colon epithelial cells by an activated Ki-Ras gene. J. Clin. Invest. 101, 1572\u20131580 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFng1855_CR11","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1158\/0008-5472.CAN-03-1953","volume":"64","author":"A Thomas-Tikhonenko","year":"2004","unstructured":"Thomas-Tikhonenko, A. et al. Myc-transformed epithelial cells down-regulate clusterin which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res. 64, 3126\u20133136 (2004).","journal-title":"Cancer Res."},{"key":"BFng1855_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biocel.2003.12.011","volume":"36","author":"RP Tucker","year":"2004","unstructured":"Tucker, R.P. The thrombospondin type 1 repeat superfamily. Int. J. Biochem. Cell Biol. 36, 969\u2013974 (2004).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFng1855_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1096\/fj.01-0332fje","volume":"16","author":"I Inoki","year":"2002","unstructured":"Inoki, I. et al. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 16, 219\u2013221 (2002).","journal-title":"FASEB J."},{"key":"BFng1855_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0140-6736(03)15172-0","volume":"363","author":"B Perbal","year":"2004","unstructured":"Perbal, B. CCN proteins: multifunctional signalling regulators. Lancet 363, 62\u201364 (2004).","journal-title":"Lancet"},{"key":"BFng1855_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/sj.bjc.6603023","volume":"94","author":"HW Hwang","year":"2006","unstructured":"Hwang, H.W. & Mendell, J.T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 94, 776\u2013780 (2006).","journal-title":"Br. J. Cancer"},{"key":"BFng1855_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O'Donnell","year":"2005","unstructured":"O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V. & Mendell, J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839\u2013843 (2005).","journal-title":"Nature"},{"key":"BFng1855_CR17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828\u2013833 (2005).","journal-title":"Nature"},{"key":"BFng1855_CR18","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1371\/journal.pbio.0020363","volume":"2","author":"B John","year":"2004","unstructured":"John, B. et al. Human microRNA targets. PLoS Biol. 2, e363 (2004).","journal-title":"PLoS Biol."},{"key":"BFng1855_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1261\/rna.5235104","volume":"10","author":"G Meister","year":"2004","unstructured":"Meister, G., Landthaler, M., Dorsett, Y. & Tuschl, T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10, 544\u2013550 (2004).","journal-title":"RNA"},{"key":"BFng1855_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc905","volume":"2","author":"RS Kerbel","year":"2002","unstructured":"Kerbel, R.S. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2, 727\u2013739 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng1855_CR21","first-page":"1931","volume":"62","author":"J Rak","year":"2002","unstructured":"Rak, J., Yu, J.L., Kerbel, R.S. & Coomber, B.L. What do oncogenic mutations have to do with angiogenesis\/vascular dependence of tumors? Cancer Res. 62, 1931\u20131934 (2002).","journal-title":"Cancer Res."},{"key":"BFng1855_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/22788","volume":"400","author":"L Chin","year":"1999","unstructured":"Chin, L. et al. Essential role for oncogenic Ras in tumour maintenance. Nature 400, 468\u2013472 (1999).","journal-title":"Nature"},{"key":"BFng1855_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1101\/gad.14.1.34","volume":"14","author":"R Ravi","year":"2000","unstructured":"Ravi, R. et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 alpha. Genes Dev. 14, 34\u201344 (2000).","journal-title":"Genes Dev."},{"key":"BFng1855_CR24","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.7521539","volume":"265","author":"KM Dameron","year":"1994","unstructured":"Dameron, K.M., Volpert, O.V., Tainsky, M.A. & Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582\u20131584 (1994).","journal-title":"Science"},{"key":"BFng1855_CR25","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/sj.onc.1201012","volume":"14","author":"BP Himelstein","year":"1997","unstructured":"Himelstein, B.P., Lee, E.J., Sato, H., Seiki, M. & Muschel, R.J. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14, 1995\u20131998 (1997).","journal-title":"Oncogene"},{"key":"BFng1855_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher, A. & Slack, F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259\u2013269 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"BFng1855_CR27","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257\u20132261 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1855_CR28","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","volume":"65","author":"Y Hayashita","year":"2005","unstructured":"Hayashita, Y. et al. A polycistronic microRNA cluster, miR-17\u201392, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628\u20139632 (2005).","journal-title":"Cancer Res."},{"key":"BFng1855_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Krutzfeldt","year":"2005","unstructured":"Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685\u2013689 (2005).","journal-title":"Nature"},{"key":"BFng1855_CR30","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz, H. et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335\u20132342 (2004).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1855","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:12:19Z","timestamp":1684433539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,30]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["BFng1855"],"URL":"https:\/\/doi.org\/10.1038\/ng1855","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1046866.496893","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,30]]}}}